|
MISPS
Myocardial Infarction Secondary Prevention Study
Ongoing trial
 |
Author(s) |
Shang H, Dai G, Hang J, Xiang Y, Wang Y, Zhang J, DU W, Mao J, Yao C, Weng W, Wen T, Zhang B
|
 |
Title(s) |
Myocardial infarction secondary prevention study (MIPS)
|
|
Reference(s) |
J Geriatr Cardiol 2006;3:116–9 |
|
Disease |
MI |
|
Purpose |
To test the hypothesis that QuiShen YiQi Dripping Pills, in combination with standard post-MI treatment, are as effective as or superior to ASA in reducing major adverse cardiac events with comparable or less side-effects |
|
Study design |
Randomised, double-blind, parallel-group |
|
Follow-up |
Aim: not stated |
|
Patients |
Aim 3600 patients, ≤ 65 years, with AMI within the previous 28 days to 2 years |
|
Treatment regimen |
QuiShen YiQi Dripping Pills or ASA |
|
Concomitant therapy |
Standard therapy as recommended by current American College of Cardiology/American Heart Association guidelines |
|
Results |
Not yet available |
|
|
|
